Latest Tax Incentives News

Page 7 of 56
Iondrive Limited has independently confirmed strong rare earth recoveries from U.S. magnet waste and gained Oklahoma government support for its first commercial processing module, advancing its U.S. commercialisation strategy.
Maxwell Dee
Maxwell Dee
31 July 2026
Sparc Technologies has secured commercial traction for its graphene additive ecosparc® with major coatings players AkzoNobel and Petro Vietnam Paint, launched a new additive range for electrostatic coatings, and marked six months of continuous operation at its green hydrogen pilot plant.
Victor Sage
Victor Sage
31 July 2026
Murray Cod Australia (ASX:MCA) reported a 53% jump in FY26 sales volumes and a 17.9% rise in customer receipts, underpinned by new retail deals with Coles and Woolworths and a focused cost-cutting program.
Ada Torres
Ada Torres
31 July 2026
Elixir Energy has advanced its Queensland Taroom Trough gas projects with successful stimulation and flow testing at Lorelle-3H, a new contingent resource booking at ATP2057, and a pipeline feasibility agreement with APA Group.
Maxwell Dee
Maxwell Dee
31 July 2026
Godolphin Resources has unveiled a significant polymetallic sulphide discovery at Cousin Jack within its Lewis Ponds Project, alongside progressing an IPO to spin out its Narraburra Rare Earths asset into Matrix Critical Minerals.
Maxwell Dee
Maxwell Dee
31 July 2026
Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.
Ada Torres
Ada Torres
30 July 2026
Alterity Therapeutics has cleared a major regulatory hurdle with the FDA endorsing a single pivotal Phase 3 trial for its ATH434 drug in Multiple System Atrophy, setting the stage for trial initiation by the end of 2026.
Ada Torres
Ada Torres
30 July 2026
Clever Culture Systems has doubled its large pharmaceutical customer base to eight, installed 34 APAS Independence instruments, and expects FY27 sales growth driven by existing and new customers. The company maintains a $1.7 million cash balance, raised $1.6 million in short-term debt, and is expanding validation services.
Ada Torres
Ada Torres
30 July 2026
Right Resources’ latest quarter reveals a promising new Reduced Intrusion-Related Gold System and high-grade tungsten discoveries at Tumbarumba, backed by a $2.7 million capital raise.
Maxwell Dee
Maxwell Dee
30 July 2026
Miramar Resources has doubled its gold Exploration Target at the Gidji JV near Kalgoorlie and completed its first drilling program at Chain Pool in over 60 years, while finalising the sale of Randalls Project and securing government grants to fund ongoing exploration.
Maxwell Dee
Maxwell Dee
30 July 2026
Parkway Corporate delivered a record $7.25 million quarterly revenue and $0.54 million EBITDA, powered by a major water infrastructure contract. The company progressed key approvals for its Queensland Brine Management Complex and struck a strategic collaboration with Hitachi to develop advanced brine concentration technology.
Victor Sage
Victor Sage
30 July 2026
PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.
Ada Torres
Ada Torres
29 July 2026

Browse the archive

Full archive